The Canadian government announced Monday a deal with American biotech firm Novavax for 76 million doses of its Covid-19 vaccine in development, if it proves to be effective against the new coronavirus.
/https://s2.mihaaru.com/photos/2020/04/02/271790_4_cf270c60710502966a6906d24c686d5e340a64f0_large.jpg)
Samples being extracted from patients showing symptoms or determined to be at high risk, to test for the COVID-19 virus, the spreading of which has claimed lives all around the globe and has pushed many countries into taking preemptive actions such as placing their borders under lockdown. PHOTO: AFP
Rae Munavvar
2020-08-31 19:31:12
The Canadian government announced Monday a deal with American biotech firm Novavax for 76 million doses of its Covid-19 vaccine in development, if it proves to be effective against the new coronavirus.
The NVX-CoV2373 vaccine candidate, which is currently in Phase 2 clinical trials to evaluate its safety and immunogenicity, could be delivered in the second quarter of 2021, Ottawa and the company said in a joint statement.
Copyright © 2025 The Edition
/https://s1.mihaaru.com/photos/2025/03/03/412239_3_0d44335ad3c46bcc013565bc8f2b060cc771eb05_large.jpg)
/https://cdn.mihaaru.com/photos/2024/11/18/405822_3_42991b287152e728fb9dc1a34b047616b3c170b2_large.jpg)
/https://s1.mihaaru.com/photos/2025/02/22/411540_3_4a48676775adcce55fa65b35db06d54c556c2d45_large.jpg)
/https://cdn.mihaaru.com/photos/2025/01/20/409609_3_8619638b962d13f7368c9bfe329a353eeeb47616_large.jpg)